BackInnoPharmax Overview

InnoPharmax Current Cash

Latest current cash for 4172.TWO: $190M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$185.79M
↓ 6.67% YoYΔ $-13.28M vs prior year quarter

Peer trimmed avg / median

Loading

InnoPharmax Current Cash History

Loading

InnoPharmax vs. peers: Current Cash Comparison

Loading

InnoPharmax Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

InnoPharmax (4172.TWO) FAQ

As of the most recent data (June 2026), 4172.TWO shows a current cash of $190M. That compares with $200M in the prior-year period — down 6.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4172.TWO's current cash is now $190M (was $200M) — a 6.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether InnoPharmax is outperforming or lagging.

Tracking 4172.TWO's current cash over time shows whether InnoPharmax is scaling, shrinking, or reshaping that part of the business. The current reading is $190M That compares with $200M in the prior-year period — down 6.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has InnoPharmax's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $190M) with ownership activity and broader fundamentals.